Leonardo DRS CFO sells 7,071 vested shares
Leonardo DRS, Inc. EVP and CFO Michael Dippold reported multiple equity compensation events and a modest stock sale.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Leonardo DRS, Inc. EVP and CFO Michael Dippold reported multiple equity compensation events and a modest stock sale. On April 1, 2026, performance and time-based restricted stock units vested and were converted into common shares, alongside new restricted stock unit awards granted at no cash cost.
To cover tax obligations from these vestings, the company withheld a total of 34,157 common shares through several transactions coded as F. On April 2, 2026, Dippold then executed an open-market sale of 7,071 common shares at $45.38 per share under a pre-arranged Rule 10b5-1 trading plan, and he held 63,778 common shares directly after the sale.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
14 txns
Insider
Dippold Michael
Role
EVP and CFO
Sold
7,071 shs ($321K)
Approx. gross sale proceeds
$321K
Approx. exercise cost
$0.00
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 7,071 | $45.38 | $321K |
| Exercise | Restricted Stock Unit | 10,360 | $0.00 | $0.00 |
| Exercise | Restricted Stock Unit | 6,815 | $0.00 | $0.00 |
| Exercise | Restricted Stock Unit | 5,451 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 33,380 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 13,858 | $45.86 | $636K |
| Grant/Award | Common Stock | 22,378 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 10,093 | $45.86 | $463K |
| Exercise | Common Stock | 10,360 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 4,673 | $45.86 | $214K |
| Exercise | Common Stock | 6,815 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 3,074 | $45.86 | $141K |
| Exercise | Common Stock | 5,451 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 2,459 | $45.86 | $113K |
Holdings After Transaction:
Restricted Stock Unit — 17,718 contracts (Direct);
Common Stock — 63,778 shares (Direct)
Footnotes (7)
- F1. Represents performance restricted stock units ("PRSUs") awarded in April 2023 under the Issuer's 2022 Omnibus Equity Compensation Plan (the "Plan") for the performance period January 1, 2023 through December 31, 2025, for which performance goals have been achieved and certified on February 19, 2026. Each PRSU represents the right to one share of the Issuer's common stock. The PRSUs vested on April 1, 2026.
- F2. Shares withheld by the Issuer to satisfy tax withholding requirements.
- F3. Represents PRSUs awarded in April 2023 under the Plan for the performance period January 1, 2023 through December 31, 2025, for which performance goals have been achieved and certified on February 19, 2026. Each PRSU represents the right to one share of the Issuer's common stock. The PRSUs vested on April 1, 2026.
- F4. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025.
- F5. Each restricted stock unit ("RSU") was granted under the Plan, and represents a contingent right to receive one share of the common stock of the Issuer or the cash equivalent thereof. One-third of the RSUs vested on each of April 1, 2024 and April 1, 2025. The remaining one-third of RSUs vested on April 1, 2026.
- F6. Each RSU was granted under the Plan and represents a contingent right to receive one share of the common stock of the Issuer or the cash equivalent thereof. One-third of the RSUs vested on each of April 1, 2025 and April 1, 2026. The remaining one-third of RSUs are scheduled to vest on April 1, 2027, subject to the Reporting Person's continued employment with the Issuer through such date.
- F7. Each RSU was granted under the Plan, and represents a contingent right to receive one share of the common stock of the Issuer or the cash equivalent thereof. One-third of the RSUs vested on April 1, 2026. The remaining RSUs are scheduled to vest one-third annually on each of April 1, 2027 and April 1, 2028, subject to the Reporting Person's continued employment with the Issuer through each date.
Key Figures
Open-market sale: 7,071 shares at $45.38
Shares held after transactions: 63,778 shares
Derivative exercises: 22,626 shares
+3 more
6 metrics
Open-market sale
7,071 shares at $45.38
Common Stock sale on April 2, 2026
Shares held after transactions
63,778 shares
Common Stock directly owned following April 2, 2026 sale
Derivative exercises
22,626 shares
Total shares from RSU/PRSU exercises (M-code) on April 1, 2026
Tax-withholding shares
34,157 shares
Common shares withheld to satisfy tax obligations (F-code)
RSU grant
33,380 shares
Common Stock granted via award on April 1, 2026
Additional RSU grant
22,378 shares
Common Stock granted via a second award on April 1, 2026
Key Terms
performance restricted stock units ("PRSUs"), restricted stock unit ("RSU"), Rule 10b5-1 trading plan, 2022 Omnibus Equity Compensation Plan, +1 more
5 terms
performance restricted stock units ("PRSUs") financial
"Represents performance restricted stock units ("PRSUs") awarded in April 2023 under the Issuer's 2022 Omnibus Equity Compensation Plan"
restricted stock unit ("RSU") financial
"Each restricted stock unit ("RSU") was granted under the Plan, and represents a contingent right to receive one share"
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
2022 Omnibus Equity Compensation Plan financial
"awarded in April 2023 under the Issuer's 2022 Omnibus Equity Compensation Plan (the "Plan")"
tax withholding requirements financial
"Shares withheld by the Issuer to satisfy tax withholding requirements."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Leonardo DRS (DRS) CFO Michael Dippold report?
Michael Dippold reported vesting and conversion of performance and time-based restricted stock units into common shares, related tax-withholding share dispositions, and an open-market sale of 7,071 Leonardo DRS common shares under a Rule 10b5-1 trading plan, while retaining a substantial remaining common stock position.
What role did restricted stock units play in the Leonardo DRS (DRS) Form 4?
The Form 4 shows multiple restricted stock unit and performance restricted stock unit awards for the CFO vesting and converting into Leonardo DRS common shares. These equity awards were granted under the company’s 2022 Omnibus Equity Compensation Plan and vest over several years based on service and performance conditions.
Was the Leonardo DRS (DRS) CFO’s stock sale discretionary or pre-planned?
The CFO’s sale of 7,071 Leonardo DRS common shares was executed under a Rule 10b5-1 trading plan adopted on June 13, 2025. Such plans are pre-arranged trading programs, which means the timing and amount of the sale were established in advance, reducing discretionary timing concerns.
AI-generated analysis. How Rhea-AI works. Not financial advice.
